February 16, 2022

Topical Discussion

Video

An Interview with Paul LaViolette

17:38

He joined SV in 2009 as a Venture Partner and in 2011 was made a Partner. Paul was promoted to Managing Partner & COO in 2014 and heads medical device investments.

Topical Discussion

Advertisement

Latest Videos

02:37

Next Generation TAVR Planning with DASI Simulations: Artificial Intelligence and Prediction-Based Algorithms

11:05

The Impact of Valve Flow Dynamics on Disease Regression and Outcomes After TAVR

00:20

Cerebral Embolic Protection – A Next Generation Approach for Contemporary TAVR Practice

05:20

Quick Takes: Hooman Allayee on the Lingering Risk of MACE for COVID-19 Patients

01:25

TCT 2024 Keynote- Insight and Inspiration With Arthur C. Brooks

33:02

Best of Endovascular Cases with Live Cases from Mount Sinai

47:01

Live Case - TTVR and Tricuspid Valve Interventions- From Clinical Trials to Clinical Practice Sinai Medical Center, Los Angeles, CA

55:10

Live Case 7 Tricuspid TEER - University of Washington Medical Center, Seattle, WA

33:29

New TAVR Systems - Instituto do Coracao (InCor), Sao Paulo, Brazil

31:30

New TAVR Systems - UPMC, Pittsburgh, PA

41:52

Live Case 8- TMVR - Mayo Clinic, Rochester, MN

03:44

Quick Takes: Britton Scheuermann on the Accuracy of the PREVENT Equations

Partner Content

Explore All

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.